Interaction of the glucocorticoid receptor with the chromatin landscape

The generality and spectrum of chromatin-remodeling requirements for nuclear receptor function are unknown. We have characterized glucocorticoid receptor (GR) binding events and chromatin structural transitions across GR-induced or -repressed genes. This analysis reveals that GR binding invariably occurs at nuclease-accessible sites (DHS). A remarkable diversity of mechanisms, however, render these sites available for GR binding. Accessibility of the GR binding sites is either constitutive or hormone inducible. Within each category, some DHS sites require the Brg1-containing Swi/Snf complex, but others are Brg1 independent, implicating a different remodeling complex. The H2A.Z histone variant is highly enriched at both inducible and constitutive DHS sites and is subject to exchange during hormone activation. The DHS profile is highly cell specific, implicating cell-selective organization of the chromatin landscape as a critical determinant of tissue-selective receptor function. Furthermore, the widespread requirement for chromatin remodeling supports the recent hypothesis that the rapid exchange of receptor proteins occurs during nucleosome reorganization.     

Modeling residual force enhancement with generic cross-bridge models

The interaction of actin and myosin through cross-bridges explains much of muscle behavior. However, some properties of muscle, such as residual force enhancement, cannot be explained by current cross-bridge models. There is ongoing debate whether conceptual cross-bridge models, as pioneered by Huxley (A.F. Huxley, Muscle structure and theories of contraction, Prog. Biophys. Biophys. Chem. 7 (1957) 255) could, if suitably modified, fit experimental data showing residual force enhancement. Here we prove that there are only two ways to explain residual force enhancement with these ‘traditional’ cross-bridge models: the first requires cross-bridges to become stuck on actin (the stuck cross-bridge model) while the second requires that cross-bridges that are pulled off beyond a critical strain enter a ‘new’ unbound state that leads to a new force-producing cycle (the multi-cycle model). Stuck cross-bridge models cannot fit the velocity and stretch amplitude dependence of residual force enhancement, while the multi-cycle models can. The results of this theoretical analysis demonstrate that current kinetic models of cross-bridge action cannot explain the experimentally observed residual force enhancement. Either cross-bridges in the force-enhanced state follow a different kinetic cycle than cross-bridges in a ‘normal’ force state, or the assumptions underlying traditional cross-bridge models must be violated during experiments that show residual force enhancement.     

Density functional theory studies of oxygen and carbonate binding to a dicopper patellamide complex

In this work we present results of density functional theory (DFT) calculations on dicopper patellamides and their affinity for molecular oxygen and carbonate. Patellamides are cyclic octapeptides that are produced by a cyanobacterium, and may show promise as therapeutics. Thus, carbonate binding to a dicopper patellamide center gives a stable cyclic octapeptide with a twist of almost 90°. The system exists in close-lying open-shell singlet and triplet spin states with two unpaired electrons in orthogonal σ^∗ orbitals on each metal center. Subsequently, we replaced carbonate with dioxygen and found a stable Cu₂(μ-O)₂ diamond shaped patellamide core. In this structure the original dioxygen bond is significantly weakened to essentially a single bond, which should enable the system to transfer these oxygen atoms to substrates. We predicted the IR and Raman spectra of the Cu₂(μ-O)₂ diamond shaped patellamide structure using density functional theory and found a considerable isotope effect on the O-O stretch vibration for ¹⁶O₂ versus ¹⁸O₂ bound structures. Our studies reveal that carbonate forms an extremely stable complex with dicopper patellamide, but that additional molecular oxygen to this system does not give a potential oxidant. Therefore, it is more likely that carbonate prepares the system for dioxygen binding by folding it into the correct configuration followed in the proposed catalytic cycle by a protonation event preceding dioxygen binding to enable the system to reorganize to form a stable Cu₂(μ-O)₂-patellamide cluster. Alternatively, carbonate may act as an inhibitor that blocks the catalytic activity of the system. It is anticipated that the Cu₂(μ-O)₂-patellamide structure is a potential active oxidant of the dicopper patellamide complex.     

Effect of seven hours intermittent suckling and flavour recognition on piglet performance

A low feed intake during the first days after weaning is predisposing for weaning diarrhoea and weight loss. In this experiment we tried to increase the feed intake of the piglets after weaning by stimulating the solid feed intake during the last two weeks before weaning by separating them from the sows for 7 h/d. In addition, the effect of flavour recognition and the interaction of flavour recognition with intermittent suckling were tested. In two consecutive weaning rounds, sows were divided over two compartments with 7 to 10 sows each. They were assigned to one of four treatments in a two factorial design: control housing/control feed (n = 7); control housing/ flavoured feed (n = 8); intermittent suckling/control feed (n = 7); intermittent suckling/ flavoured feed (n = 9). After weaning, for each round 3 pens of 6 pigs were selected per treatment group. All these piglets received the same feed with the same flavour at the same concentration. Contrary to the expectations, intermittent suckling decreased the solid feed intake during the last two weeks before weaning. Flavour addition to the creep feed did not increase feed intake or other performance parameters before and after weaning, nor did it interact with intermittent suckling. Although after intermittent suckling pigs ate less creep feed before weaning, they did not perform worse after weaning. However, to increase feed intake after weaning, longer periods of separation might be necessary.     

Response of 40-70 kg barrows and gilts to increasing ideal protein concentrations in the diet

In Belgium, crossing a hybrid dam with a Piétrain sire leads to a rather lean and meaty fattening pig type. A digestibility trial and a performance trial were carried out to determine protein needs of this pig type. Six experimental diets with increasing protein content were formulated with 0.65-1.25% apparent ileal digestible lysine. The feeds were formulated to the ideal protein composition, with lysine as the reference amino acid. Standardised and apparent digestible amino acid values of the extreme diets were measured in a digestibility trial with four gilts cannulated at the end of the ileum, with an average initial and final BW of 39.1 kg and 55.3 kg, respectively, using a protein-free feed to estimate the basal endogenous N-losses. A performance trial at 13-18 weeks of age (40-70 kg BW) was performed with barrows and gilts separately at six protein levels, balanced in lysine, threonine, methionine and tryptophan. The experiment consisted of 11 pens (of 5 animals) per treatment and per sex. Average daily gain (ADG) and feed conversion ratio (FCR) reached maximal performance within the experimental lysine range for both sexes. Based on the ADG-data for barrows and on the ADG- and FCR-data for gilts, a protein level for optimal performance corresponded with a standardised ileal digestible lysine concentration of 0.89% for barrows and of 1.07-1.09% for gilts.     

A four year longitudinal sero-epidemiology study of <Emphasis Type="Italic">Neospora caninum</Emphasis>in adult cattle from 114 cattle herds in south west England: Associations with age,herd and dam-offspring pairs

Background

Neosporosis caused by the protozoan parasite Neospora caninum, is an economically important cause of abortion, stillbirth, low milk yield, reduced weight gain and premature culling in cattle. Consequently, a seroepidemiological study of N. caninum antibodies was conducted in England with 29,782 samples of blood taken from 15,736 cattle from 114 herds visited on three occasions at yearly intervals. Herds were categorised into lower (< 10%) and higher (≥ 10%) median herd seroprevalence. Hierarchical models were run to investigate associations between the sample to positive (S/P) ratio and herd and cattle factors.

Results

Ninety-four percent of herds had at least one seropositive cow; 12.9% of adult cattle had at least one seropositive test. Approximately 90% of herds were seropositive at all visits; 9 herds (8%) changed serological status between visits. The median N. caninum seroprevalence in positive herds was 10% (range 0.4% to 58.8%). There was a positive association between the serostatus of offspring and dams that were ever seropositive. In the hierarchical model of low seroprevalence herds there was no significant association between S/P ratio and cattle age. There was a significantly lower S/P ratio in cattle in herds that were totally restocked after the foot-and-mouth epidemic of 2001 compared with those from continuously stocked herds and cattle purchased into these herds had a higher S/P ratio than homebred cattle. In the model of high seroprevalence herds the S/P ratio increased with cattle age, but was not associated with restocking or cattle origin.

Conclusion

There were no strong temporal changes in herd seroprevalence of N. caninum but 90% of herds had some seropositive cattle over this time period. Vertical transmission from seropositive dams appeared to occur in all herds. In herds with a high seroprevalence the increasing S/P ratio in 2–4 year old cattle is suggestive of exposure to N. caninum: horizontal transmission between adult cattle, infection from a local source or recrudescence and abortions. Between-herd movements of infected cattle enhance the spread of N. caninum, particularly into low seroprevalence herds. Some restocked herds had little exposure to N. caninum, while in others infection had spread in the time since restocking.

     

Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria

The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil−dapsone (CPG−DDS) for the treatment of uncomplicated falciparum malaria.

Methods

Open-label clinical trial comparing CPG−DDS alone or with artesunate 4, 2, or 1 mg/kg at medical centers in Blantyre, Malawi and Farafenni, The Gambia. The trial was conducted between June 2002 and February 2005, including 116 adults (median age 27 years) and 107 children (median age 38 months) with acute uncomplicated Plasmodium falciparum malaria. Subjects were randomized into 4 groups to receive CPG–DDS alone or plus 4, 2 or 1 mg/kg of artesunate once daily for 3 days. Assessments took place on Days 0−3 in hospital and follow-up on Days 7 and 14 as out-patients. Efficacy was evaluated in the Day 3 per-protocol (PP) population using mean time to reduce baseline parasitemia by 90% (PC90). A number of secondary outcomes were also included. Appropriate artesunate dose was determined using a pre-defined decision matrix based on primary and secondary outcomes. Treatment emergent adverse events were recorded from clinical assessments and blood parameters. Safety was evaluated in the intent to treat (ITT) population.

Results

In the Day 3 PP population for the adult group (N = 85), mean time to PC90 was 19.1 h in the CPG−DDS group, significantly longer than for the +artesunate 1 mg/kg (12.5 h; treatment difference −6.6 h [95%CI −11.8, −1.5]), 2 mg/kg (10.7 h; −8.4 h [95%CI −13.6, −3.2]) and 4 mg/kg (10.3 h; −8.7 h [95%CI −14.1, −3.2]) groups. For children in the Day 3 PP population (N = 92), mean time to PC90 was 21.1 h in the CPG−DDS group, similar to the +artesunate 1 mg/kg group (17.7 h; −3.3 h [95%CI −8.6, 2.0]), though the +artesunate 2 mg/kg and 4 mg/kg groups had significantly shorter mean times to PC90 versus CPG−DDS; 14.4 h (treatment difference −6.4 h [95%CI −11.7, −1.0]) and 12.8 h (−7.4 h [95%CI −12.9, −1.8]), respectively. An analysis of mean time to PC90 for the Day 14 PP and ITT populations was consistent with the primary analysis. Treatment emergent, drug-related adverse events were experienced in 35.3% (41/116) of adults and 70.1% (75/107) of children; mostly hematological and gastroenterological. The nature and incidence of adverse events was similar between the groups. No dose-related changes in laboratory parameters were observed. Nine serious adverse events due to any cause occurred in five subjects including two cases of hemolysis believed to be associated with drug treatment (one adult, one child). One adult died of anaphylactic shock, not associated with investigational therapy.

Conclusions

CPG–DDS plus artesunate demonstrated advantages over CPG–DDS alone for the primary efficacy endpoint (mean time to PC90) except in children for the 1 mg/kg artesunate dose. Based on a pre-defined decision matrix, the primary endpoint in the child group supported an artesunate dose of 4 mg/kg. Secondary endpoints also supported a 4 mg/kg artesunate dose to take forward into the remainder of the development program.

Trial Registration

ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT00519467","term_id":"NCT00519467"}}NCT00519467